Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Monoclonal antibodies used to prevent COVID-19 in immunocompromised people aren’t active against new virus variants.
Protecting the immunocompromised is not only a matter of health equity, it’s critical to ending the pandemic.
Hospitals are filling up with COVID-19 patients and other medical conditions are going untreated.
As schools reopen for in-person learning, what should bone marrow transplant recipients do?
Experts say treatment decisions should depend on the individual and factors such as cancer stage.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.